| 丁苯酞治疗2型糖尿病轻度认知障碍疗效观察 |
| 投稿时间：2014-10-31 修订日期：2014-12-22 点此下载全文 |
| 引用本文：王传刘,林海燕,万金星.丁苯酞治疗2型糖尿病轻度认知障碍疗效观察[J].医学研究杂志,2015,44(7):75-77 |
| DOI：
10.11969/j.issn.1673-548X.2015.07.021 |
| 摘要点击次数: 1703 |
| 全文下载次数: 904 |
|
| 基金项目:浙江省医药卫生科学研究基金计划项目(2008A164) |
|
| 中文摘要:目的 探讨丁苯酞胶囊治疗2型糖尿病伴轻度认知障碍的临床疗效。方法 90例诊断为2型糖尿病伴轻度认知障碍患者随机分成对照组和治疗组,治疗组在对照组基础上给予丁苯酞胶囊治疗,6个月后比较两组蒙特利尔认知评估(MoCA)评分和及事件相关电位P300,并观察药物不良反应。结果 与对照组相比,治疗组MoCA量表评分提高(P<0.01),P300潜伏期缩短、波幅增高(P<0.05),且未发现明显不良反应。结论 丁苯酞胶囊能提高2型糖尿病伴轻度认知障碍患者的认知功能,值得临床上进一步推广和应用。 |
| 中文关键词:2型糖尿病 轻度认知障碍 丁苯酞 |
| |
| Clinical Effect of Butylphthalide Soft Capsules in the Treatment of Type 2 Diabetic Patients with Mild Cognitive Impairment |
|
|
| Abstract:Objective To discuss the effect of butylphthalide soft capsules in the treatment of type 2 diabetic patients with mild cognitive impairment. Methods Ninety cases of diagnosed type 2 diabetic with mild cognitive impairment were randomly divided into two groups: the treatment group (n=45) and the control group (n=45). Patients in both groups were treated with the traditional therapy, but those in the study treatment group were given butylphthalide soft capsules. MoCA and P300 were used as the effect judge standard after June. Results Compared with the control group, the MoCA score was increased in the treatment group(P<0.01), P300 latency was shorten and P300 amplitude was increased (P<0.05). Conclusion Butylphthalide capsules can improve cognitive function in patients with type 2 diabetes patients with mild cognitive impairment, and worthy of further clinical promotion and application. |
| keywords:Type 2 diabetes mellitus Mild cognitive impairment Butylphthalide |
| 查看全文 查看/发表评论 下载PDF阅读器 |
